Literature DB >> 9382743

Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.

D H Jones1, C D Partidos, M W Steward, G H Farrar.   

Abstract

The induction of mucosal immune responses by oral delivery of vaccines is highly desirable. However vaccines to be used in this context will require protection from degradation in the gut and the use of specialised vehicles for their delivery and presentation. Using the biodegradable and biocompatible polymer, poly(lactide-co-glycolide), we have encapsulated bacterial and viral proteins, synthetic peptides and plasmid DNA in microparticles, and compared the immune responses resulting from their oral and parenteral administration to mice. The successful induction of specific systemic and mucosal humoral immune responses, as well as cell-mediated immune responses, demonstrates the potential of this polymer formulation as a vehicle for the oral delivery of vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9382743

Source DB:  PubMed          Journal:  Behring Inst Mitt        ISSN: 0301-0457


  3 in total

1.  Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.

Authors:  Douglas J Hanlon; Paulomi B Aldo; Lesley Devine; Ayesha B Alvero; Anna K Engberg; Richard Edelson; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-01-18       Impact factor: 3.886

Review 2.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

3.  Uptake of amplifiable fragments of retrotransposon DNA from the human alimentary tract.

Authors:  A Forsman; D Ushameckis; A Bindra; Z Yun; J Blomberg
Journal:  Mol Genet Genomics       Date:  2003-10-11       Impact factor: 3.291

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.